Skip to content
VuFind
    • English
    • Deutsch
    • Español
    • Français
    • Italiano
    • 日本語
    • Nederlands
    • Português
    • Português (Brasil)
    • 中文(简体)
    • 中文(繁體)
    • Türkçe
    • עברית
    • Gaeilge
    • Cymraeg
    • Ελληνικά
    • Català
    • Euskara
    • Русский
    • Čeština
    • Suomi
    • Svenska
    • polski
    • Dansk
    • slovenščina
    • اللغة العربية
    • বাংলা
    • Galego
    • Tiếng Việt
    • Hrvatski
    • हिंदी
    • Հայերէն
    • Українська
    • Sámegiella
    • Монгол
Advanced
  • Retraction on “Dihydromyriceti...
  • Cite this
  • Text this
  • Email this
  • Print
  • Export Record
    • Export to RefWorks
    • Export to EndNoteWeb
    • Export to EndNote
  • Permanent link
Retraction on “Dihydromyricetin attenuates inflammation through TLR4/NF-kappa B pathway”

Retraction on “Dihydromyricetin attenuates inflammation through TLR4/NF-kappa B pathway”

Bibliographic Details
Main Authors: Jing Nianshui, Li Xinnan
Format: Article
Language:English
Published: De Gruyter 2021-07-01
Series:Open Medicine
Online Access:https://doi.org/10.1515/med-2021-0331
  • Holdings
  • Description
  • Similar Items
  • Staff View

Internet

https://doi.org/10.1515/med-2021-0331

Similar Items

  • Dihydromyricetin attenuates inflammation through TLR4/NF-kappaB pathway
    by: Jing Nianshui, et al.
    Published: (2019-09-01)
  • Levistolide a Attenuates Acute Kidney Injury in Mice by Inhibiting the TLR-4/NF-κB Pathway
    by: Shi J, et al.
    Published: (2024-12-01)
  • Dihydromyricetin Nanoparticles Alleviate Lipopolysaccharide-Induced Acute Kidney Injury by Decreasing Inflammation and Cell Apoptosis via the TLR4/NF-κB Pathway
    by: Hongmei Yin, et al.
    Published: (2024-08-01)
  • Dihydromyricetin Attenuates Streptozotocin-induced Liver Injury and Inflammation in Rats via Regulation of NF-κB and AMPK Signaling Pathway
    by: Lei Chen, et al.
    Published: (2020-02-01)
  • Dihydromyricetin attenuates Escherichia coli lipopolysaccharide-induced ileum injury in chickens by inhibiting NLRP3 inflammasome and TLR4/NF-κB signalling pathway
    by: Yicong Chang, et al.
    Published: (2020-05-01)

Search Options

  • Search History
  • Advanced Search

Find More

  • Browse the Catalog
  • Browse Alphabetically
  • Explore Channels
  • Course Reserves
  • New Items

Need Help?

  • Search Tips
  • Ask a Librarian
  • FAQs